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Abstract
mHealth tools to help people manage chronic illnesses have surged in popularity, but evi-
dence of their effectiveness remains mixed. The aim of this study was to address a gap in
the mHealth and health psychology literatures by investigating how individual differences in
psychological traits are associated with mHealth effectiveness. Drawing from regulatory
mode theory, we tested the role of locomotion and assessment in explaining why mHealth
tools are effective for some but not everyone. A 13-week pilot study investigated the effec-
tiveness of an mHealth app in improving health behaviors among older veterans (n = 27)
with poorly controlled Type 2 diabetes. We developed a gamified mHealth tool (DiaSocial)
aimed at encouraging tracking of glucose control, exercise, nutrition, and medication adher-
ence. Important individual differences in longitudinal trends of adherence, operationalized
as points earned for healthy behavior, over the course of the 13-week study period were
found. Specifically, low locomotion was associated with unchanging levels of adherence
during the course of the study. In contrast, high locomotion was associated with generally
stronger adherence although it exhibited a quadratic longitudinal trend. In addition, high
assessment was associated with a marginal, positive trend in adherence over time while low
assessment was associated with a marginal, negative trend. Next, we examined the rela-
tionship between greater adherence and improved clinical outcomes, finding that greater
adherence was associated with greater reductions in glycated hemoglobin (HbA1c) levels.
Findings from the pilot study suggest that mHealth technologies can help older adults
improve their diabetes management, but a “one size fits all” approach may yield suboptimal
outcomes.
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Introduction
The number of American adults with diabetes has quadrupled since 1980 and associated costs
have reached over 200 billion dollars annually[1], leaving both patients and health care work-
ers in search of ways to improve diabetes management. Although everyday decisions about
eating habits, exercise, and medication adherence are critical to controlling progression of
the disease, many patients report barriers to enacting these behaviors[2,3]. Mobile health
(mHealth) technologies use mobile and wireless devices to improve health, and are viewed as a
promising medium to help patients overcome barriers and achieve their health goals[4,5], but
most existing studies focus on average treatment effects that may not be experienced uniformly
across target populations. Indeed, theories from social and personality psychology suggest that
health interventions might provide a better fit for some individuals than others[6,7], offering
potential insights into heterogeneous mHealth effects. Thus, the objective of the present pilot
research was to explore the interplay of individual differences in regulatory mode and mHealth
in motivating lifestyle change among older veterans, a population experiencing a heavy diabe-
tes burden that is also underrepresented in the mHealth intervention literature.
Diabetes in older adults and veterans
Rates of Type 2 diabetes in older adults are higher than other populations, with approximately
20% of Americans over the age of 65 suffering from diabetes[1]; and consequences of the dis-
ease can be especially serious including heightened mortality and reduced functionality[8].
Despite greater disease prevalence and associated risks among older adults, they are underrep-
resented in controlled trials designed to improve diabetes management[9,10]. Veterans are
another large population at high risk of diabetes and its complications, and older veterans
often have worse health outcomes than older adults in the general population[11]. Concerns
related to diabetes self-management are exacerbated by the fact that primary care providers,
who typically manage diabetes in the initial stages of disease, do not devote sufficient time to
diabetes management[12]. In resident-staffed general medicine clinics, residents spent an
average of 5 out of 25 minutes on diabetes, and evaluation of glycated hemoglobin (HbA1c)
levels were addressed only 40% of the time[12].
Given the time constraints experienced by health care providers and growing prevalence of
diabetes in the U.S., it is imperative that persons with diabetes are equipped with tools that
raise awareness of the impact of their lifestyle choices and motivate them to better self-manage
their diabetes. Moreover, it is equally critical that we find ways of identifying who tends to ben-
efit most from different types of self-management interventions to ensure that patients are
provided with care that matches their needs and preferences. With the unique health needs of
veterans and the underrepresentation of older adults in diabetes interventions research consid-
ered, we sought to explore the role of theoretically relevant psychological traits in moderating
effectiveness of an mHealth app promoting better management of diabetes.
mHealth and chronic disease management
Recent polls show that a majority of US adults own a smartphone[13], and interest in mHealth
technologies is not restricted to the young—most older adults report being eager to adopt
mobile fitness technologies[14,15]. mHealth technologies offer many advantages that are
appealing for interventions including their widespread accessibility, cost-effective delivery,
and flexibility to content tailoring[4]. These benefits of mHealth technologies have led to a
surge in their use to address a major health challenge—chronic disease self-management.
Although there is encouraging evidence of success[16], several reviews of the effectiveness of
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mHealth interventions have yielded mixed results for treatment adherence[17,18] and clinical
outcomes[19,20].
Inconsistencies in findings highlight some of the challenges endemic to longitudinal
mHealth interventions including high drop-out rates and weakened engagement over time
[21,22]. While these problems have often been noted as barriers to maximizing the impact of
mHealth initiatives, theory-based approaches to understanding who will benefit from such
interventions have been underutilized. To address this gap, we drew on insights from the psy-
chology of motivation to explore individual differences that could explain heterogeneity in the
effectiveness of an mHealth intervention to improve diabetes self-management.
Individual differences and mHealth effectiveness
Even as the use of mHealth in interventions has surged, its integration with health and person-
ality psychology is nascent[23]. Illustrating this point are content analyses of mHealth applica-
tions that have shown low integration of apps with health behavior theory[24,25]. One
particularly important connection between theory and mHealth could lie in understanding the
role of personality in shaping engagement with health interventions[26]. The present research
offers an exploration of this connection by focusing on a personality dimension implicated in
motivation that could moderate the effectiveness of our mHealth intervention, viz., regulatory
mode.
Regulatory mode. Regulatory mode theory posits that two independent orientations
underlie most self-regulation, locomotion and assessment[27,28]. Locomotion refers to a pref-
erence for movement from state to state and is captured by the phrase “just do it.” Assessment,
on the other hand, reflects a preference for evaluating states and alternatives and can be char-
acterized by the phrase “do the right thing.” The two dimensions of regulatory mode are
orthogonal[29] and differentially related to a wide range of phenomena including regret[30],
burnout[31,32], and risk-taking[33].
We propose that regulatory mode orientations may influence effectiveness of interven-
tions that are centered around goal-setting and self-monitoring, as in the case of our
mHealth application DiaSocial, developed internally by the research team for the study.
Locomotors, in particular, might benefit from an mHealth app’s role in providing patients
with specific, salient health behavior goals through features like gamification. Gamification
is a term that refers to integrating game mechanisms into non-game contexts, such as using
leaderboards and point systems that reward certain behavior[34]. A gamification system that
outlines goals for various health behaviors could instigate behavior change in locomotors
who tend to act on goals efficiently[35] and with little procrastination[36]. In accordance
with this reasoning, we expect our mHealth intervention to be especially effective for high
(vs. low) locomotors, as they should be more eager to act on the goals provided by the gamifi-
cation point system.
We also expect assessors to benefit from the intervention, although through a different
mechanism, which is self-monitoring. Self-monitoring is considered important in the manage-
ment of chronic diseases[37,38], and many mHealth tools endeavor to facilitate tracking of
health behavior[39,40]. However, self-monitoring with mHealth tools often requires some
component of manual data entry, imposing the burden of substantial effort and non-trivial
demands on patients. Accordingly, mHealth tracking tools may not be equally appealing to
everyone. Given assessors’ preference for comparison and self-evaluation, we predict that high
(vs. low) assessment will be positively associated with engagement with an mHealth tool and
sustained behavior change over the course of an intervention, as indicated by self-reported
treatment adherence. In other words, we expect the emphasis on self-monitoring to “fit” with
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assessors’ orientation towards evaluation, increasing engagement with the app, thereby
improving diabetes outcomes[41].
The present research
The present research explored the utility of the mHealth tool described above, the DiaSocial
app, in improving diabetes outcomes in a sample of older veterans. A central objective of our
pilot was to explore whether individual differences in regulatory mode moderated the effec-
tiveness of our mHealth intervention in increasing healthy behavior and improving clinical
outcomes. We predicted that locomotion and assessment would both independently moderate
the effectiveness of the app due to different mechanisms. More specifically, we expected the
gamification features to be particularly motivating to high (vs. low) locomotors who are eager
to act on salient goals, resulting in greater adherence. Similarly, we expected the tracking fea-
tures of the app would appeal to those high (vs. low) in assessment, motivating treatment




All research participants were veteran patients affiliated with an endocrinology clinic of a VA
medical center. Patients aged 60 and above having a known diagnosis of Type 2 diabetes for
>3 years, and poorly controlled (HbA1c > 7.9%) were eligible to participate. Exclusion criteria
included blindness, deafness, a diagnosis of serious mental illness (active psychosis, bipolar
disorder, schizophrenia, borderline personality disorder, active alcohol or other substance mis-
uses) and homelessness. A study signup flyer was posted in the clinic waiting room and staff
shared the study participation opportunity with eligible patients. Seventy-nine patients
expressed initial interest in the study and were sent letters detailing the study and formally
inviting them to participate. Thirty-one patients responded to the letters, two withdrew before
the beginning of the study period, leaving a final sample of twenty-nine research participants
aged 61–86, including three women, and three who self-identified as African American. Two
additional recruits dropped out shortly after study initiation, leaving 27 total participants
(Mage = 67.56, SDage = 5.81). Participant exclusions and drop-outs are summarized in Fig 1
and additional detail is presented in the CONSORT checklist in S1 File. Initially, we sought to
recruit about 88 participants, but our final sample size was limited by funding for the project,
which came internally from the research institutions of a subset of the authors and the Theo
und Friedl Schöller Foundation.
Participants received a Samsung Galaxy Tab 3 with data plan, a Fitbit One, as well as $20 in
travel support for each of the clinic visits. The participants were allowed to keep the devices at
study end. The study was reviewed and approved by the University of Maryland Baltimore
IRB, and all participants provided signed informed consent. The study was also registered on
ClinicalTrials.gov (#NCT02127216).
Procedure
The study protocol is available as supplementary information in S2 File. Participants were
enrolled and completed an initial questionnaire including demographic information and a
personality inventory during their regular diabetes clinic visit. Participants were then block
randomized into usual care or one of four experimental conditions, with patients stratified by
age, baseline HbA1C, and BMI. At study outset, participants completed a 2-hour group
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training session where they were given a Samsung Galaxy Tab 3 preloaded with the DiaSocial
app, configured to match their experimental group (i.e., team grouping, provider communica-
tion), and a Fitbit One. Operation of the tablet, DiaSocial app and Fitbit were demonstrated,
and participant questions were addressed. Individuals were instructed to use the app daily, and
were encouraged to earn points by recording their progress in achieving better diabetes self-
care goals through managing glucose level, exercise, diet, and medication adherence. Partici-
pants who were assigned to teams met their teammates in person during the training session
and were able to continue to interact online through the app.
The treatment period began the Monday following training, which occurred during Febru-
ary, and lasted for 13 weeks to assess trends in healthy behavior (as assessed by gamification
Fig 1. CONSORT participant flow diagram.
https://doi.org/10.1371/journal.pone.0192807.g001
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points earned through the app) and changes in HbA1C. The duration of the intervention was
constrained by available resources for the pilot study, therefore 13 weeks was selected because
it represented the shortest amount of time at which reliable changes in our primary clinical
outcome of interest, HbA1C, could be observed.
Manipulations. In order to pilot test different mHealth engagement strategies, a parallel
research design with five conditions was employed. The research participants were assigned to
a usual care group (n = 5) or one of four experimental conditions: (T1) Patients using the app
individually without clinician or peer engagement (n = 5); (T2) Patients using the app with cli-
nician engagement features (n = 5); (T3) Patients using the app with peer engagement features
(n = 6), and (T4) Patients using the app with both clinician engagement and peer engagement
features (n = 6). Participants were randomly assigned to conditions using the blockrand pack-
age in R with a block size of 6 and stratifying participants across four blocking factors (age,
gender, HbA1C, and BMI). Neither patients nor clinicians were blind to treatment conditions.
A summary of descriptive statistics by experimental conditions can be found in Table 1.
Patients in all four experimental conditions received the same app self-monitoring features.
Patients were able to view if their scores were trending at, above, or below the point goals for
each behavior. Provider engagement features allowed a clinician to view a patient’s behavior
score trends and raw data (e.g. glucose reading or minutes exercised) and communicate with
the patient. Similarly, team features allowed for communication between team members and
allowed team members to view each other’s progress on daily and weekly points, and their
team’s progress in relation to another team.
Measures
Regulatory mode. Regulatory mode was assessed with adapted 6-item brief versions of
the locomotion (e.g., “I enjoy actively doing things, more than just watching and observing”;
α = .60) and assessment scales (e.g., “I spend a great deal of time thinking about my positive
and negative characteristics”; α = .70)[28]. Response categories ranged from 1 (Strongly Dis-
agree) to 5 (Strongly Agree), and average scores for each scale were used for analyses.
HbA1C. Glycated hemoglobin (HbA1C) measures were taken as our key clinical outcome
given that higher HbA1C measures have been associated with greater diabetes complications
and poorer health outcomes, and controlling HbA1C is a primary therapeutic target[42].
HbA1C levels were assessed via a blood draw and laboratory testing at the VA clinical labora-
tory. If patients had their HbA1C levels assessed within 3 months of being recruited and
enrolled in the study, this was treated as their baseline measure to avoid undue burden from
another blood test. We then aimed to assess post-study HbA1C levels 90 days after the
Table 1. Summary statistics by condition for enrolled sample.
Control T1 T2 T3 T4
(n = 5) (n = 5) (n = 5) (n = 6) (n = 6)
M SD M SD M SD M SD M SD
Age 66.40 4.93 65.40 4.72 72.00 9.30 66.00 5.18 68.17 3.66
Locomotion 3.30 0.36 3.67 0.88 3.83 0.47 3.89 0.51 3.61 0.43
Assessment 2.83 0.26 2.86 0.65 2.83 0.94 2.78 0.83 2.88 0.50
Days App Used - - - - 61.20 21.87 67.80 20.98 61.67 30.69 69.50 31.15
Total Score - - - - 4436.60 3037.35 4326.40 1815.09 4360.00 2750.48 5173.33 3055.62
Pre-A1C 9.12 0.64 9.44 1.42 9.34 0.93 8.47 0.66 8.66 .36
Post-A1C 8.78 0.89 10.14 3.09 8.96 0.55 8.36 0.60 8.06 .78
https://doi.org/10.1371/journal.pone.0192807.t001
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beginning study. Given differences in recruitment times and regular clinic appointments for
each patient, however, there was variability in the dates at which HbA1C levels were measured
(S1 Appendix for details).
Adherence. Health behaviors related to diabetes management were allocated daily points
when reported in the app, and these points were used to assess treatment adherence during the
intervention. Points were allocated for achieving daily goals related to reporting and reaching
target levels of glucose, exercise, nutrition, and medication adherence (S1 Appendix). Glucose,
diet, and medication tracking were entered manually by participants, but exercise tracking
could be synchronized with their Fitbit or entered manually. Scores across different domains
of adherence were significantly correlated with each other and therefore scores were summed
together to form an overall adherence score. Daily overall adherence scores were then summed
to form weekly scores and one total score representing adherence over the course of the
13-week study. Each participant’s individual weekly scores are presented by domain in S1
Appendix.
Statistical method
When designing our pilot study, we were primarily interested in how individual differences
could moderate the impact of an mHealth intervention with a focus on regulatory mode
dimensions of locomotion and assessment. However, our research design also included several
treatment conditions to explore the feasibility and appeal of different app features (e.g., teams,
provider communication). As such, we conducted one set of analyses to explore how different
treatments impacted the effectiveness of the mHealth app and a second set of analyses that
focused on the role of regulatory mode. One-way ANCOVA and linear mixed effects regres-
sion models were used to explore these research questions and were performed with IBM SPSS
24 software[43]. Given the exploratory nature of our pilot study, we did not control for multi-
ple comparisons and set a threshold of significance at p = .05 for each test.
First, we explored between-group treatment effects on overall adherence and HbA1C in
our analyses. We did not expect strong between-group effects given some of the limitations in
the piloted communication features and the small sample sizes per group. Therefore, to
explore treatment effects on adherence, we performed a one-way ANCOVA testing mean dif-
ferences in total adherence during the study. Next, we tested for interactions of treatment
effect and time on HbA1C. If treatment conditions interacted with time, then this would con-
stitute evidence that the app features affected the degree of change in an important clinical
outcome.
After exploring between-group differences, we then turned to testing the hypothesized role
of regulatory mode in promoting greater self-management adherence over the course of the
13-week intervention. Debriefing interviews revealed that participants did not fully utilize
communication features of the app, perhaps because this aspect of the software was still in
need of some refinement. Given that the communication features were not fully utilized, small
sample sizes per condition (n< 7), and mostly null differences between treatment groups, we
examined the role of regulatory mode among participants assigned to the experimental arms
of the study independent of treatment condition, simply controlling for assignment to differ-
ent study arms rather than exploring possible interaction effects of treatment group and regu-
latory mode.
We were particularly interested in exploring how regulatory mode affected not only overall
adherence throughout the study, but also trends in weekly adherence. With engagement and
behavior change maintenance being a concern in mHealth interventions[21,22], we expected
that weekly adherence could exhibit a curvilinear trend over the course of the intervention’s 13
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weeks. Specifically, we thought it plausible that patients would show an initial upwards trend
in adherence behavior as they built off the excitement of a new intervention and any early suc-
cesses. However, we recognized that the novelty of the intervention could begin to wane as
participants progressed through the later stages of the intervention, as has been observed in
the case of other mHealth interventions. Moreover, a plot of the observed levels of average
adherence at each week suggested that a quadratic trend might better approximate the pattern
of adherence over time than a linear trend (see S1 Appendix Therefore, we explored both lin-
ear and quadratic effects of time in our analyses with regulatory mode. We hypothesized that
locomotion and assessment would each interact with a quadratic effect of time such that loco-
motors and assessors were better able to maintain their strong adherence over the course of
the 13-week duration of the study.
After testing for the hypothesized role of regulatory mode on adherence, we sought to
explore whether measures of adherence were associated with improvements in our clinical
outcome, HbA1C. Such a relationship would provide initial support for the validity of our
gamification point structure and would illustrate the utility of identifying personality charac-
teristics associated with greater adherence. Thus, we examined the interaction effect of total
adherence score and time to predict HbA1C levels. We expected an interaction effect such that




Before proceeding with inferential tests, we first created a boxplot to explore the distribution
of adherence scores to identify possible outliers (see S1 Appendix). Satisfied with the distribu-
tion of our outcome variable, we proceeded to conduct a one-way ANCOVA, including a
treatment factor of the four treatment arms of the study and age as a covariate. The control
group was not included in these analyses because adherence was assessed with points earned
through the app. Age was unrelated to total adherence(F(1, 17) = -0.34, p = .5, ηp2 = .02). In
addition, there was a non-significant treatment effect, F(3, 17) = 0.14, p = .93, ηp2 = .02. Table 1
summarizes the differences in total adherence between treatment groups. As expected, there
were no differences in adherence levels across treatment conditions.
Changes in HbA1C
We again plotted boxplots to explore the distribution of HbA1C to identify possible outliers.
Two individuals were identified as having outlier HbA1C levels (see S1 Appendix) and were
excluded from further analyses, yielding a final sample size of 25. A linear mixed effects model
was then estimated to test for differences between treatment conditions in the rate of change
of HbA1C from baseline to post-intervention. Model specifications are further detailed in S2
Appendix.
As evident from Table 2, between-group comparisons detected no significant effects on
HbA1C change over time. As noted earlier, however, we did not expect between-group differ-
ences to emerge given the relatively small sample sizes per condition. Moreover, we were par-
ticularly interested in examining the effects of regulatory mode as a moderator of the
effectiveness of an mHealth intervention. In the proceeding analyses, we explore the role of
individual differences in regulatory mode in adherence and, in turn, the role of adherence in
yielding greater clinical benefits from an intervention.
Regulatory mode and effectiveness of mHealth
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Individual difference results
Adherence
In our pilot study, we were particularly interested in exploring the moderating role of regula-
tory mode on the effectiveness of an mHealth intervention. Based on hypotheses derived from
regulatory mode theory, we expected trends in weekly adherence scores to depend on locomo-
tion and assessment as locomotors would benefit from the goal-directing aspects of the app
while assessors would benefit from the app’s facilitation of self-monitoring. As such, we
hypothesized that adherence would, on average, exhibit a downward quadratic trend, but that
the negative trend in the second half of the study would be attenuated by high locomotion and
high assessment. To this end, we introduced locomotion and assessment as predictors of
adherence scores and tested potential cross-level interaction effects with the linear and qua-
dratic effects of time. Model specification details are reported in S2 Appendix. Analyses per-
taining to specific adherence domains (glucose, nutrition, exercise, and medication) can also
be found in S2 Appendix.
Relevant descriptive statistics are reported in Table 3. Observed trends in adherence for
individuals high and low in locomotion and assessment are illustrated with Figs 2 and 3,
respectively.
Results of linear mixed models are summarized in Table 4 (and a plot of residual vs. pre-
dicted values is reported in S1 Appendix). Notably, there was a non-significant linear effect of
time on adherence, B = .22, t(224.42) = 0.12, p = .90. In addition, there was a non-significant of
quadratic effect of time, B = -0.51, t(223.68) = -1.96, p = .34. However, these effects were quali-
fied by significant interactions. First, there was a significant interaction between the linear
trend in time and assessment, B = 7.31, t(226.59) = 2.50, p = .01. Furthermore, there was a sig-
nificant interaction effect of the quadratic term for time and locomotion, B = -2.13, t(223.78) =
- 2.04, p< .05. In light of the significant interaction effects, we performed conditional analyses
to examine the linear trend in adherence at low (-1 SD) and high (+1 SD) levels of assessment
(Fig 4) and the quadratic trend in adherence at low (-1 SD) and high (+1 SD) levels of locomo-
tion (Fig 5).
Table 2. Model estimates predicting HbA1C.
Est. SE t p
Fixed Effects
Intercept 9.07 0.35 26.21 < .001
Age -0.03 0.02 -1.20 .24
Time -0.34 0.39 -0.88 0.39
T1 -0.38 0.56 -0.68 .50
T2 0.38 0.50 0.75 0.46
T3 -0.66 0.46 -1.43 .16
T4 -.0.37 0.47 -0.79 .43
Time x T1 -0.49 0.64 -0.78 .45
Time x T2 -0.04 0.55 -0.07 .94
Time x T3 0.31 0.53 0.59 .56
Time x T4 -0.49 0.53 -0.93 .36
Random Effects
σ2 0.38 0.12 < .01
τ00 0.21 0.14 .14
σ2 = residual, τ00 = variance in intercept by participant.
https://doi.org/10.1371/journal.pone.0192807.t002
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Assessment. Conditional analyses decomposing the Time x Assessment interaction effect
found a marginal decrease in adherence over time at low levels of assessment, B = -4.39, t
(226.52) = -1.73, p = .08. In contrast, there was a marginal increase in adherence over time at
high levels of assessment, B = 4.82, t(224.71) = 1.83, p = .07. Controlling for individual locomo-
tion, treatment condition, and age, these results suggest that individuals higher in assessment
might benefit from a self-monitoring oriented mHealth intervention to a greater extent than
individuals low in assessment. However, the marginal significance of our simple slope analyses
underscores the need for caution in interpretation of these findings, and reveal a need for fur-
ther research into this question. This is especially important given that the plot depicting the
association between observed scores of assessment and adherence did not reveal a strong rela-
tionship (Fig 3).
Locomotion. Next, we proceeded to decompose the Time2 x locomotion interaction
with conditional analyses. A non-significant quadratic effect of time on adherence scores at
low levels of locomotion was found, B = 0.60, t(224.34) = 0.75, p = .45. In contrast, there was
a significant quadratic effect of time on adherence at high levels of locomotion, B = -1.61
t(222.98) = -2.24, p = .03. In order to better understand the quadratic trend, we examined the
Fig 2. Observed values of for weekly adherence scores by individual level of locomotion. Colors represent
standardized locomotion scores of participants and lines show average weekly score for low (< 3.67 scale score) and
high (> 3.67 scale score) locomotors as defined by a median split.
https://doi.org/10.1371/journal.pone.0192807.g002
Table 3. Descriptive statistics and Bivariate correlations (N = 22).
M SD 1 2 3 4
1. Age 67.82 6.07 - -
2. Locomotion 3.79 0.50 -.44
3. Assessment 2.84 0.63 .06 .06
4. Days App Used 65.09 25.38 .06 .32 .16
5. Total Adherence Score 4591.59 2558.03 -.13 .41ǂ .03 .85
ǂ p < .10.
p < .05.
 p < .001.
https://doi.org/10.1371/journal.pone.0192807.t003
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instantaneous rate of change in adherence scores at weeks 3 and 11—the midpoints of the first
and second half of the study.
A significant positive rate of change in adherence scores at week 3 for high locomotors
was found, B = 14.48, t(223.06) = 2.35, p = .02. However, high locomotors also exhibited a mar-
ginally negative rate of change in adherence scores at week 11, B = -11.34, t(223.07) = -1.79,
p = .08. This suggests that healthy behaviors increased among high locomotors for the first
half of the study, but their motivation began to diminish as the study continued. Even so, high
Fig 3. Observed values of for weekly adherence scores by individual level of assessment. Colors represent
standardized locomotion scores of participants and lines show average weekly score for low (< 2.83 scale score) and
high (> 2.83 scale score) assessors as defined by a median split.
https://doi.org/10.1371/journal.pone.0192807.g003
Table 4. Model estimates predicting weekly adherence scores.
Est. SE t p
Fixed Effects
Intercept 383.12 38.15 10.04 < .001
Age -.09 7.95 -0.01 .13
T2 -49.02 74.36 -0.66 .52
T3 4.74 64.25 0.07 .94
T4 60.67 64.68 0.94 .36
Time 0.22 1.81 0.12 .90
Locomotion 193.64 90.90 2.13 < .05
Assessment -7.37 57.39 -0.13 .90
Time2 -0.51 .53 -0.96 .34
Time x Locomotion 2.61 3.53 0.74 .46
Time x Assessment 7.31 2.92 2.50 .01
Time2 x Locomotion -2.13 1.05 -2.04 .04
Time2 x Assessment 1.24 0.83 1.49 .14
Random Effects
σ2 10553.13 999.71 < .001
τ00 29182.90 11134.59 < .01
σ2 = residual, τ00 = variance in intercept by participant.
https://doi.org/10.1371/journal.pone.0192807.t004
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locomotors likely benefit from accumulating a greater number of points throughout the
entirety of the study. Indeed, locomotion was associated with marginally higher adherence
scores at week 3 (B = 149.04, t(16.00) = 1.64, p = .12), significantly higher scores at week 7
(B = 193.64, t(16.09) = 2.13, p< .05), and marginally higher scores at week 11 (B = 169.93,
t(15.71) = 1.88, p = .08). This suggests that even as individuals high in locomotion were trend-
ing toward lower adherence scores in the latter half of the study, they were still marginally out-
performing those low in locomotion.
Conclusion. An exploration of adherence to healthy behavior found that individual differ-
ences in regulatory mode predicted distinct trends over time. In particular, individuals high in
assessment trended toward generally improving their adherence over time in contrast to indi-
viduals low in assessment who trended toward showing decreases in adherence over time.
Interestingly, unlike assessment, locomotion was associated with distinct quadratic patterns in
Fig 4. Patterns of predicted weekly adherence scores over time at high and low levels of assessment are depicted.
https://doi.org/10.1371/journal.pone.0192807.g004
Fig 5. Patterns of predicted weekly adherence scores over time at high and low levels of locomotion are depicted.
https://doi.org/10.1371/journal.pone.0192807.g005
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adherence whereby high locomotion was associated with an upward trend in adherence during
the first half of the study and a downward trend in the latter half, but still generally higher
adherence than low locomotion. That assessment and locomotion were associated with differ-
ent patterns in adherence suggest that greater investigation of regulatory mode in the context
of mHealth behavioral intervention effectiveness is warranted. Notably, these results also
pertain to self-reported healthy behavior, and these results would be magnified if these self-
reported behaviors were associated with clinical benefits. As such, we next turned to investigat-
ing the relationship between total adherence over the course of the study and changes in
HbA1C from baseline to post-intervention.
Changes in HbA1C
Our mHealth intervention should improve clinical outcomes for diabetes patients to the extent
that it motivates lifestyle changes in important domains like glucose tracking, exercise, medica-
tion adherence, and nutrition. We tested for an interaction between adherence, operationa-
lized as total score earned through DiaSocial’s point system, and time on HbA1C levels. Total
scores were standardized to enhance interpretation, time was dummy coded (0 = baseline,
1 = post-intervention), and treatment conditions (effects coded) and age (centered around the
mean) were again included as covariates in these analyses. Time was modeled as a fixed effect,
but intercepts were allowed to vary randomly. The two participants identified as having outlier
HbA1C values were excluded from analyses, yielding a final sample size of 20. A comparison
of analyses with different exclusion criteria is also reported in S3 Appendix.
Table 5 reports descriptive statistics and correlations and Fig 6 depicts observed trends in
the relationship between adherence scores and HbA1C over time. Table 6 reports results from
the estimated model (and a plot of residual vs. predicted values presented in S1 Appendix).
The linear mixed effects model was consistent witha significant effect of time reported in the
table that can be interpreted as a significant decline in HbA1C at mean levels of total score,
B = -0.48, t(18) = -2.95, p< .01. In addition, there was a non-significant effect of total score,
indicating that there was no difference in baseline HbA1C between high and low scorers,
B = 0.24, t(23.23) = 1.45, p = .16. Consistent with our prediction, there was a significant inter-
action effect of time and total score, B = -0.59, t(18) = -3.58, p< .01. Simple slopes analyses
were conducted to further decompose the interaction.
Results of the simple slopes analyses included a non-significant relationship between time
and HbA1C at low (-1 SD) total scores, B = 0.11, t(18) = 0.46, p = .65. In contrast, time was sig-
nificantly associated with lower A1C levels when app usage was high, B = -1.07, t(18) = -4.64,
Table 5. Descriptive statistics and Bivariate correlations (N = 20).
M SD 1 2 3 4 5 6
1. Age 68.25 6.19 –
2. Locomotion 3.77 0.52 -.43 ǂ –
3. Assessment 2.84 0.71 .08 .06 –
4. Days App Used 66.25 24.84 -.01 .37 .26 –
5. Total Adherence Score 4537.75 2355.43 -.17 .46 .16 .86 –
6. Baseline HbA1c 8.80 0.88 -.28 .42ǂ .22 .44ǂ –
7. Post HbA1C 8.31 0.75 .04 -.25 -.15 -.29 -.45ǂ .36
ǂ p < .10.
p < .05.
 p < .001.
https://doi.org/10.1371/journal.pone.0192807.t005
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p< .001. The above findings are depicted in Fig 7. These results suggest that participants who
exhibited strong adherence, as indicated by self-reported diet, exercise, medication, and glu-
cose monitoring, showed about a 1.0 point drop in HbA1C from baseline to post-intervention
on average, controlling for age and treatment condition. In contrast, those who exhibited
Fig 6. Observed values of HbA1C by individual adherence score. Colors represent standardized total adherence scores of participants and lines show
average HbA1C levels for low (< 4954 total score) and high (> 4954 scale score) adherers as defined by a median split.
https://doi.org/10.1371/journal.pone.0192807.g006
Table 6. Model estimates predicting HbA1C.
Est. SE t p
Fixed Effects
Intercept 8.79 0.16 54.92 < .001
Age -0.04 0.02 -1.83 .09
T2 0.77 0.25 3.06 < .01
T3 -0.20 0.23 -0.89 .39
T4 -0.25 0.22 -1.11 .28
Time -0.48 0.16 -2.98 < .01
Adherence 0.23 0.16 1.45 .16
Time x Adherence -0.59 0.16 -3.58 < .01
Random Effects
σ2 .26 .09 < .01
τ00 .22 .14 .12
σ2 = residual, τ00 = variance in intercept by participant.
https://doi.org/10.1371/journal.pone.0192807.t006
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mean levels of adherence showed less of a decline in HbA1C, at about .48 points on average.
Finally, individuals who exhibited low adherence showed no change in baseline and post-
intervention HbA1C.
Discussion
The primary objective of this pilot study was to explore potential individual differences in the
effectiveness of an mHealth intervention to improve health behaviors and clinical outcomes
among older adults with diabetes. We argued that regulatory mode, i.e., the degree to which an
individual was a locomotor or an assessor, would moderate the effects of an intervention that
required goal setting and included gamification. While we found only marginal relationships
between assessment and adherence, our results were consistent with the prediction that effec-
tiveness of the intervention is conditional on locomotion. Our pilot study provided prelimi-
nary evidence that implementation of an mHealth behavioral intervention would differentially
impact treatment adherence according to individual differences in regulatory mode, and treat-
ment adherence was further associated with improvements in levels of HbA1C.
Our research extends the literature on the use of mHealth tools to improve diabetes man-
agement[44–46] by emphasizing the role of personality differences. An important implication
that follows is the need for greater attention to the interplay between personality and mHealth
interventions to better understand their effectiveness. Consistent with our expectation that the
app’s use of goal-setting would be a good fit with locomotors’ eagerness to engage in goal-ori-
ented movement[35,36], locomotion was associated with greater overall treatment adherence.
Interestingly, high locomotors also exhibited a quadratic pattern in adherence—while scores
were high overall for locomotors, they increased from the beginning to the mid-point of the
study before beginning to trend downwards.
Evidence that locomotors like to multitask[47] suggest one possible reason why locomotors
might begin to show a decline in adherence—a propensity to get bored more easily. Future
Fig 7. Change in predicted HbA1C over time as a function of total adherence scores.
https://doi.org/10.1371/journal.pone.0192807.g007
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interventions could try to mitigate this by introducing novel goals and challenges or levels
throughout the intervention period to maintain locomotors’ interest. These findings support
the argument that mHealth tools can serve as a catalyst for locomotors to direct their energy
toward better disease management when they narrow focus to specific goals with features like
gamification.
In contrast to our findings related to locomotion, the association between assessment and
adherence was less clear. Although linear trends in adherence over time were found to depend
on individual differences in assessment, the positive trend for high assessors, who we predicted
would enjoy the self-monitoring features of our mHealth app, did not reach significance (nor
the negative trend for low assessors). Thus, it is difficult to infer whether these findings are
inconsistent with evidence showing benefits for a “fit” between achievement contexts and an
individual’s level of assessment[41] and to what extent. However, we argue that these findings,
along with support for the moderating role of locomotion, highlight the promise in theory-
driven investigation of fit between personality and mHealth interventions and underscore the
need for more research along these lines.
Our pilot study also offered initial support for the validity of our gamification system in
which we allocated points for different health behaviors. With greater amounts of points being
associated with greater declines in HbA1C, we have encouraging evidence that our point sys-
tem is incentivizing achievable, clinically important health behaviors. The association between
points and improved clinical outcomes also suggests that most individuals are honest and
accurate in their reporting even though past research has identified shortcomings of self-report
measures of nutrition[48] and physical activity[49,50].
Limitations and future directions
In our pilot, we also explored the effectiveness of different app features including communica-
tion with provider and peer teams. Overall, treatment effects were not supported, but this was
not unexpected given some of the limitations of our study, which bear further elaboration.
Most notably, the sample size was small, meaning the study was underpowered. Though the
large number of observations per participant mitigated the small sample size to some extent,
our ability to detect differences across treatment conditions was limited and we did not have
the power to explore interactions between individual differences in regulatory mode and the
effectiveness of specific treatments. In addition, because the communication features in the
app were rudimentary and not heavily used during the study, we did not expect significant dif-
ferences across conditions in the pilot. Favorably, the app design enabled us to collect intensive
longitudinal data on each participant, allowing us to make the most of our smaller sample size
when examining trends in self-reported adherence behavior. Unfortunately, HbA1C levels
were also assessed for each patient at different times, depending on their regular patient care
schedule, thereby introducing some noise in our ability to detect differences in clinical out-
comes. In the next trial testing the effectiveness of DiaSocial (or a similar mHealth app), we
will seek to expand our sample size, refine within-app messaging, and have more consistent
clinical measures to address these limitations.
It should be noted that our intervention was delivered via a tablet rather than smartphone,
which might be a better fit for older adults[13]. Reinforcing other mHealth research with older
adults[51,52], our pilot study suggests that the use of mHealth tools to improve management
of chronic diseases in older adults is highly feasible, but additional research should test for dif-
ferences in delivery by tablets and smartphones, and for differences in effectiveness according
to individual health and technology literacy. Our sample also presents limitations to the gener-
alizability of our findings. More specifically, most of our participants were white male veterans,
Regulatory mode and effectiveness of mHealth
PLOS ONE | https://doi.org/10.1371/journal.pone.0192807 March 7, 2018 16 / 21
which is consistent with other research with veteran samples[53], but additional research with
more balanced ratios of men, women and races is needed to explore how regulatory mode con-
tributes to mHealth success among women and different cultures. This is especially true given
some evidence of gender differences in effectiveness of lifestyle interventions among veterans,
with women benefitting more than men[54].
Importantly, our findings also raise questions about how to craft interventions that would
benefit low locomotors and assessors. For example, future research could explore implement-
ing manipulations of regulatory mode that have been used in laboratory-based research[55]
through messages delivered via the app. Manipulating regulatory mode in this manner might
enable even those typically low in locomotion and assessment to capitalize on the intervention.
It will also be critical to explore how healthcare organizations and professionals can adopt and
operationalize tailored mHealth through implementation science research.
Conclusion
The widespread use of mobile technology, cost-effective cloud computing infrastructure and
broad cellular network coverage in the U.S. makes mHealth a promising and pragmatic candi-
date for helping patients with diabetes improve their diabetes self-management. Overall, the
relatively high engagement levels seen in our pilot are encouraging and suggest that mHealth
tools are a viable medium to deliver chronic disease interventions and to monitor self-care
among older adults, consistent with evidence that older adults are indeed interested in using
mHealth technologies[14,15,51,52]. Our pilot study provides initial evidence of individual dif-
ferences in the effectiveness of an mHealth tool, offering an important contribution to the
mHealth literature that is guided by psychological theory. In order to leverage the advantages
of mHealth tools for all people, we must continue developing our understanding of what types
of designs will be motivating to different people. A failure to do so will blunt the impact of
mHealth interventions and leave some individuals behind.
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